GLP-1s for Midlife Weight Gain: Who They’re Right For — and Who They’re Not
Semaglutide and tirzepatide produce 15–21% average weight loss in trials — and two-thirds of it returns within a year of stopping. An honest clinical look at who GLP-1s serve, who they don’t, and what to test first.